INTRODUCTION: The anal transition zone (ATZ) after ileal pouch anal anastomosis (IPAA) for ulcerative colitis is considered at risk for dysplasia and persistent or recurrent disease activity. The long-term fate of the ATZ and the effects of histologic changes on defecatory function are not well-known. METHODS: To evaluate the inflammatory and preneoplastic changes of the ATZ in patients without preoperative dysplasia, yearly biopsies of the ATZ were obtained and functional results recorded on a questionnaire/diary. Histologic changes were correlated with simultaneous assessment of defecatory function. RESULTS: Between 1992 and 2006, 225 patients underwent a stapled IPAA. A total of 238 successful biopsies of the ATZ were performed. There was no dysplasia found. Acute inflammation was noted in 4.6%, chronic inflammation in 84.9%, and normal mucosa in 10.5% of cases. Patients with chronic inflammation reported an average of 6.2+/-1.7 bowel movements/day and 93.2% of them were able to delay a bowel movement for at least 30 min. The presence of chronic ATZ inflammation did not seem to have a negative impact on function, with 96.1% of patients reporting perfect continence, and only 5.3% using protective pads. CONCLUSIONS: Preservation of the ATZ in selected patients is safe and offers excellent long-term functional results. New onset dysplasia was not noted. Chronic inflammation had limited clinical impact. Presence of ATZ inflammation in a total of 89.5% of patients warrants life-long surveillance with biopsies.
INTRODUCTION: The anal transition zone (ATZ) after ileal pouch anal anastomosis (IPAA) for ulcerative colitis is considered at risk for dysplasia and persistent or recurrent disease activity. The long-term fate of the ATZ and the effects of histologic changes on defecatory function are not well-known. METHODS: To evaluate the inflammatory and preneoplastic changes of the ATZ in patients without preoperative dysplasia, yearly biopsies of the ATZ were obtained and functional results recorded on a questionnaire/diary. Histologic changes were correlated with simultaneous assessment of defecatory function. RESULTS: Between 1992 and 2006, 225 patients underwent a stapled IPAA. A total of 238 successful biopsies of the ATZ were performed. There was no dysplasia found. Acute inflammation was noted in 4.6%, chronic inflammation in 84.9%, and normal mucosa in 10.5% of cases. Patients with chronic inflammation reported an average of 6.2+/-1.7 bowel movements/day and 93.2% of them were able to delay a bowel movement for at least 30 min. The presence of chronic ATZinflammation did not seem to have a negative impact on function, with 96.1% of patients reporting perfect continence, and only 5.3% using protective pads. CONCLUSIONS: Preservation of the ATZ in selected patients is safe and offers excellent long-term functional results. New onset dysplasia was not noted. Chronic inflammation had limited clinical impact. Presence of ATZinflammation in a total of 89.5% of patients warrants life-long surveillance with biopsies.
Authors: Henry S Tilney; Vasilis Constantinides; Adonis S Ioannides; Paris P Tekkis; Ara W Darzi; Munther J Haddad Journal: J Pediatr Surg Date: 2006-11 Impact factor: 2.545
Authors: M G O'Riordain; V W Fazio; I C Lavery; F Remzi; N Fabbri; J Meneu; J Goldblum; R E Petras Journal: Dis Colon Rectum Date: 2000-12 Impact factor: 4.585
Authors: C Durno; P Sherman; K Harris; C Smith; A Dupuis; B Shandling; D Wesson; R Filler; R Superina; A Griffiths Journal: J Pediatr Gastroenterol Nutr Date: 1998-11 Impact factor: 2.839
Authors: Fabrizio Michelassi; John Lee; Michele Rubin; Alessandro Fichera; Kristen Kasza; Theodore Karrison; Roger D Hurst Journal: Ann Surg Date: 2003-09 Impact factor: 12.969
Authors: Maria E Litzendorf; Arthur F Stucchi; Susana Wishnia; Amy Lightner; James M Becker Journal: J Gastrointest Surg Date: 2010-03 Impact factor: 3.452
Authors: Alessandro Fichera; Mark T Silvestri; Roger D Hurst; Michele A Rubin; Fabrizio Michelassi Journal: J Gastrointest Surg Date: 2008-11-18 Impact factor: 3.452